This course is designed for practicing urologists, urologists -in-training, and allied health professionals who are involved with urolithiasis and endourology. Other medical specialists may derive benefits from the course, including internists and family practice physicians.
Course Description/Purpose
A variety of minimally invasive approaches is available for the treatment of upper tract stones, and it is advisable that the general urologist be equipped to offer a full spectrum of treatment options. As such, one of the objectives of this course is to review the basic principles of endoscopy and shock wave lithotripsy, as well as to provide guidance for the selection of appropriate treatment modalities. New technologies and techniques to facilitate these procedures will be reviewed; and tips to recognize, treat and avoid complications will be presented. However, surgical treatment of upper tract stones is only part of the comprehensive management of stone disease. This course will additionally review the pathophysiology of stone disease and provide a simplified diagnostic program and treatment algorithm for the prevention of recurrent stones. At the completion of this course, the practitioner should be able to provide comprehensive medical and surgical care for the patient with current or previous stones.
Learning Objectives
Upon completion of this course, participants should be able to:
Understand the pathophysiology of stone disease
Perform a diagnostic metabolic evaluation and formulate a rational treatment plan for stone prevention, including dietary measures and medication
Describe the mechanism of action and indications for medical expulsive therapy
Examine current imaging techniques for urolithiasis and understand how to apply them
Be aware of current and new endoscopes and instrumentation
Apply the basic principles of ureteroscopy and percutaneous renal surgery in order to safely and consistently perform successful endoscopic treatment for upper tract stones
Identify and manage the complications of ureteroscopy and PCNL
Compare the differences in current lithotripters
Review the complications and limitations of shock wave lithotripsy
Understand and apply principles of radiation safety
Select and apply an appropriate treatment modality for upper tract stones of a particular size, location and composition
Diagnose and properly manage stones in pregnant women and children
Select appropriate treatment for patients with stones in anomalous kidneys
Understand the economics of stone disease as well as the particulars of correct coding for endourologic treatments
Scientific Program – 15.75 AMA PRA Category 1 Credits™
Friday, December 10, 2010
6 – 7:00 a.m.
Continental Breakfast &Registration
Session I
7 – 7:30 a.m.
Medical Evaluation: Comprehensive and Simplified Approaches
Glenn M. Preminger, MD
7:30 – 7:50 a.m.
Hypercalciuria: Pathophysiology and Management
Glenn M. Preminger, MD
7:50 – 8:10 a.m.
Hyperoxaluria: Pathophysiology and Management
Dean G. Assimos, MD
8:10 – 8:30 a.m.
Hypocitraturia and Gouty Diathesis
Glenn M. Preminger, MD
8:30 – 9:00 a.m.
Dietary Therapy
Dean G. Assimos, MD
9 – 9:20 a.m.
Uric Acid and Cystine Stones: Etiology and Management
Margaret S. Pearle, MD, PhD
9:20 – 9:40 a.m.
Infection and Drug-Induced Stones
Dean G. Assimos, MD
9:40 – 10 a.m.
Break
10 – 10:20 a.m.
Pathogenesis of Stone Disease
James E. Lingeman, MD
10:20 – 10:40 a.m.
Medical Expulsive Therapy: Why, When and How?
Ray Leveillee, MD
10:40 a.m. – Noon
Case Discussion and Questions: Medical Management in Action
Noon – 1 p.m.
Lunch
Session II
1 – 1:40 p.m.
Percutaneous Renal Access and Stone Treatment Made Easy
James E. Lingeman, MD
1:40 – 2 p.m.
Exiting the Kidney: Big Tubes, Small Tubes, No Tubes
Raymond J. Leveillee, MD
2 – 2:30 p.m.
Complications of Percutaneous Nephrostolithotomy
Thomas Jarrett, MD
2:30 – 2:50 p.m.
Break
2:50 – 3:30 p.m.
Shockwave Lithotripsy: Technology and Technique
James E. Lingeman, MD
3:30 – 5 p.m.
Panel: Questions and Cases
Meeting Adjourns
Saturday, December 11, 2010
7 – 7:30 a.m.
Continental Breakfast & Registration
Session III
7:30 – 8:10 a.m.
Instrumentation: Seeing, Fragmenting and Extracting
Raymond J. Leveillee, MD
8:10 – 8:40 a.m.
Ureteroscopy - The Basics: How to Do It the Same Way Every Time
Margaret S. Pearle, MD, PhD
8:40 – 9:10 a.m.
Ureteroscopic Management of Renal and Ureteral Calculi: Tips and Tricks
Glenn M. Preminger, MD
9:10 – 9:30 a.m.
Break
9:30 – 10:00 a.m.
Complications of Ureteroscopy: How to Avoid Them and How to Handle Them
Dean Assimos, MD
10 – 10:30 a.m.
Stones in Pregnancy
Brian Matlaga, MD
10:30 – 10:50 a.m.
Radiation Safety
Glenn M. Preminger, MD
10:50 a.m. – Noon
Panel: Questions and Answers
Noon – 1:00 p.m.
Lunch
Session IV
1 – 1:30 p.m.
Management of Stones in Patients with Anomalous Kidneys
Tom Jarrett, MD
1:30 – 2:00 p.m.
Management of the Pediatric Stone Patient
Brian Matlaga, MD
2 – 2:30 p.m.
Imaging: Pre-op Planning and Follow-up
Margaret S. Pearle, MD, PhD
2:30 – 2:50 p.m.
Break
2:50 – 3:30 p.m.
Treatment Selection: Evidence-based
Margaret S. Pearle, MD, PhD
3:30 – 3:50 p.m.
The Economics of Stone Removal and the Mysteries of Coding Explained
Raymond J. Leveillee, MD
3:50 – 5 p.m.
Panel: Questions and Cases
Meeting Adjourns
Course Director
Margaret S. Pearle, MD, PhD
Professor of Urology and Internal Medicine
Department of Urology
The University of Texas Southwestern Medical Center
Dallas, TX
Faculty
Dean G. Assimos, MD
Professor, Surgical Sciences
Vice Chair, Department of Urology
Wake Forest University School of Medicine
Winston-Salem, NC
Thomas W. Jarrett, MD
Professor and Chairman of Urology
The George Washington University School of Medicine
Washington, DC
Raymond J. Leveillee, MD, FRCS-G
Professor of Clinical Urology
Radiology & Biomedical Engineering
Chief, Division of Endourology, Laparoscopy and Minimally Invasive Surgery
University of Miami
Miami, FL
James E. Lingeman, MD
Volunteer Clinical Professor
Department of Urology
Indiana University School of Medicine
Indianapolis, IN
Brian R. Matlaga, MD, MPH
Associate Professor
Johns Hopkins Medical Institutions
Director of Stone Disease
Director of Ambulatory Care
James Buchanan Brady Urological Institute
Baltimore, MD
Glenn M. Preminger, MD
Director, Comprehensive Kidney Stone Center
Professor of Urologic Surgery
Division of Urologic Surgery
Duke University Medical Center
Durham, NC
Meeting Location
Park Hyatt Washington, DC
Washington, DC
Find a sophisticated sanctuary in Washington's fashionable West End Georgetown neighborhood within this elite Washington, DC, hotel. Just steps from boutique shopping and minutes to the White House and other historic sites, the striking Tony Chi-designed Park Hyatt Washington offers travelers exceptional accommodations in a premier location. Award-winning dining, uncompromising service and other comfortable touches make this urbane DC hotel an enclave of refined taste.
To hold a reservation, a major credit card number must be provided.
Guest Room Rate: $225.00 single/double occupancy. Reference the American Urological Association to receive the special group rate. Once the AUA group block is full, which may be prior to the cut-off date, the AUA is unable to guarantee rooms at this rate or this hotel.
Cut-off Date: Wednesday, November 17, 2010. Guest rooms may not be available at the AUA special rate after this date.
Check In: 3 p.m. Check Out: Noon Parking: Valet parking is available at the hotel for $40/overnight or $20/day.
Transportation: There are three airports in the vicinity of the Park Hyatt Washington. Ronald Reagan Washington National Airport is just 5 miles/15 minutes from the hotel and typical one-way taxi fare is $20-25; Washington-Dulles International Airport is 27 miles/45 minutes from the Park Hyatt Washington with typical one-way taxi fare of $60-65; and Baltimore-Washington International Airport is 33 miles/60 minutes away with typical one-way taxi fare of $60-70. Travel time and fares dependent on time of day and traffic conditions.
Car Rental: Avis is offering special discounted rates to all meeting attendees. Reservations can be made by calling 1-800-331-1600; reference the AUA Avis Worldwide Discount (AWD) number J907607 or visit www.avis.com. Be sure to enter the AWD number J907607 and "Best" in the rate code to receive the available discount.
AUA Member: $600
AUA Non-member: $725
Allied Healthcare Professional Member: $375
Allied Healthcare Professional Non-Member : $425
Cancellation Policy
Through November 5, 2010, the cancellation fee is $75. If you cancel between November 5, 2010 and November 19, 2010, the cancellation fee is $125. There are no refunds after November 19, 2010.
The AUA Education & Research has the right to cancel this course if a minimum enrollment is not reached by Monday, November 15, 2010. If the AUA Education & Research cancels this course, registration fees will be refunded in full and notification will be sent by Thursday, November 18, 2010.
Conference Confirmation
A written confirmation will be sent from our office approximately two weeks after your registration is received and processed.
Continuing Medical Education Accreditation
The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The AUA takes responsibility for the content, quality, and scientific integrity of this CME activity.
Credit Designation
The American Urological Association designates this educational activity for a maximum of 15.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
AUAER Disclosure Policy
As a provider accredited by the ACCME, the AUA must insure balance, independence, objectivity and scientific rigor in all its activities.
All faculty participating in an educational activity provided by the AUA are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the faculty's relationships may influence the educational content with regard to exposition or conclusion and resolve any conflicts of interest prior to the commencement of the educational activity.
Unlabeled or Unapproved Use of Drugs or Devices
It is the policy of the AUA to require the disclosure of all references to unlabeled or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to unlabeled or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
Disclaimer
The opinions and recommendations expressed by faculty, authors, and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.
Evidence-Based Content
As a provider of continuing medical education accredited by the ACCME, it is the policy of the AUA to review and certify that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
Special Assistance
The American Urological Association (AUA), an organization accredited for Continuing Medical Education (CME), complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, a written request should be submitted at least one month in advance. For additional assistance with your request, please call 410-689-4002.
